Profile picture
, 6 tweets, 2 min read
My Authors
Read all threads
A team of surgeons at a Chennai hospital performed a bilateral lung transplant (double-lung transplant) on a patient of COVID-19

This was the first lung transplant conducted on a COVID-19 patient in Asia

newsbytesapp.com/timeline/india…
The patient who received the transplant is a 48-year-old man from Delhi

He tested positive for the coronavirus infection on June 8 and had sustained severe lung damage due to COVID-related fibrosis
A statement from the hospital said, "His condition continued to worsen in spite of ventilator support, he was airlifted to MGM Healthcare in Chennai from Ghaziabad on July 20"
On August 27, the patient underwent a bilateral lung transplant

Dr. KR Balakrishnan, Chairperson and Director of Cardiac Sciences and Director of the Heart and Lung Transplant Program at MGM Healthcare, led the transplant along with a team of specialists
Dr. Rao, who is the MGM Healthcare Co-Director, said, "Both his lungs are working well now and we have removed ECMO support"
newsbytesapp.com/timeline/india…
The donor was a 34-year-old man who had been declared brain dead at the Apollo Gleneagles Global Hospital after suffering an intracerebral hemorrhage

The donor's heart, lungs, kidneys, and skin went to different hospitals in Chennai
Missing some Tweet in this thread? You can try to force a refresh.

Keep Current with NewsBytes

Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

More from @NewsBytesApp see all

Profile picture
NewsBytes
@NewsBytesApp
Coronavirus vaccine tracker: When will the one be ready?
newsbytesapp.com/timeline/scien…
Oxford-AstraZeneca vaccine -

The vaccine developed by Oxford University in collaboration with the pharmaceutical firm AstraZeneca is undergoing phase 2 trials in India and phase 3 trials in other parts of the world
The vaccine candidate—called AZD1222 (formerly ChAdOx1 nCoV-19)—is being manufactured by the Serum Institute of India in India

It is expected to be ready by December 2020 with an estimated price of $4 (Rs. 295)
Read 9 tweets
Profile picture
NewsBytes
@NewsBytesApp
A 33-year-old man in Hong Kong has contracted COVID-19 twice this year in what is said to be the first documented case of reinfection
newsbytesapp.com/timeline/world…
The man had been infected earlier this year in March and got reinfected in August, the study said

According to the pre-print study, the man's second case of COVID-19 occurred 142 days after the first bout
The 33-year-old had first tested positive for the virus on March 26

He experienced a cough, sore throat, fever, and headache

During the second infection, the man tested positive during entry screening at the Hong Kong airport on August 15

He remained asymptomatic this time
Read 9 tweets
Profile picture
NewsBytes
@NewsBytesApp
Hyderabad-based Bharat Biotech has been allowed to conduct a trial to test administer its COVID-19 vaccine candidate through the skin (intradermal vaccine delivery)
newsbytesapp.com/timeline/india…
The method is said to be more effective as it requires a lower dose of vaccine compared to intramuscular routes, thus lowering the per injection cost

The vaccine candidate, called COVAXIN, is already undergoing trials for intramuscular vaccine delivery
Bharat Biotech, which developing COVAXIN in collaboration with the Indian Council of Medical Research (ICMR), has now become the first Indian company to be experimenting a potential vaccine in both intradermal and intramuscular methods
Read 6 tweets

Embed code for your website

×
Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!